Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Cooperative Studies Program (CSP)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

CSP #556: The Effectiveness of rTMS in Depressed VA Patients

 

Data Sharing Statement

What's available?

Research data

Available Documentation

Dates Data are Available

Currently available

Access Criteria

Investigators associated with VA or non-VA nonprofit, academic, or research institutions may submit a request to Kousick.Biswas@va.gov. Investigators may be asked to provide further documentation such as a study proposal.

All requests are reviewed for scientific and ethical merit. Access is contingent upon approval by the requestor’s Institutional Review Board (IRB) and, if applicable, a VA Research and Development (R&D) Committee. To gain access, requestors must sign a VA data use agreement. Requestors must be fully compliant with VA data security, privacy, and human subjects requirements

Study Characteristics

Objectives

To determine if repetitive Transcranial Magnetic Stimulation (rTMS) helps people with depression who have not been helped by medications or who have not been helped enough by medications, and possibly have comorbid post-traumatic stress disorder (PTSD) and/or a history of substance abuse

Era of Service

All

Population

Male and female Veterans diagnosed with treatment-resistant major depression (TRMD) at VA medical centers.

All participant met the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for Major Depressive Disorder (MDD) and had failed at least two prior pharmacological interventions. Veterans with PTSD or history of substance use were not excluded.

Study Design

Randomized, double-blinded, intent-to-treat, two-arm, superiority parallel clinical trial

Interventions 

  • Active comparator: rTMS
  • Placebo comparator: Sham rTMS using placebo device that simulates active rTMS 

Time Period

July 2012 - March 2017

Setting

National

N

164

Response Rate

N/A

Recruitment Method

Multiple methods including, but not limited to: 

  • Provider referral
  • Flyers posted in VA hospitals
  • Review of the VA administrative databases
  • Mailed recruitment postcards

Staff at the clinical sites referred potential study participants. Study participants were selected from the entire cohort of patients referred for outpatient or inpatient psychiatric treatment at the clinical sites.  

Compensation

Depended on each staged reached in the study (range: $40-400):

  • Up to 1 week of treatment ($40)
  • Treatment weeks 2-6 ($300)
  • Follow-up visits 1-6 ($60)

Data Collected

Primary outcome

  • Success or failure to achieve remission from depression, assessed by the Hamilton Rating Scale for Depression (HRSD24)

Secondary outcomes

  • Depression measured by Montgomery-Asberg Depression Rating Scale and the Beck Depression Inventory
  • Suicidal ideation measured by Beck Scale for Suicide Ideation
  • Quality of life measured by the Veterans RAND 36-Item Health Survey
  • Cognitive function as measured by a neuropsychological battery 

Other assessments

  • Demographics, medical history, physical exam, laboratory, toxicology, pregnancy test and medication use
  • Depression, suicidal ideation, hopelessness, and antidepressant treatment history
  • Substance use and abuse, in particular alcohol abuse
  • Trauma, life stressors, post-traumatic stress, and PTSD
  • Experience, expression, and control of anger
  • Cognitive impairment and function

Data Collection Methods

  • Structured clinical interview for DSM-IV
  • Medical records
  • Laboratory reports
  • Related documents from study sites

The CSP Coordinating Center (CSPCC) at Perry Point served as the centralized data management center for the study. Outcome measures were assessed at pre-, mid-, and several post-treatment time points.

Funding Source

VA Cooperative Studies Program (CSP)

Contact

Kousick.Biswas@va.gov

Selected Publication

Mi Z, Biswas K, Fairchild JK, Davis-Karim A, Phibbs CS, Forman SD, Thase M, Georgette G, Beale T, Pittman D, McNerney MW, Rosen A, Huang GD, George M, Noda A, Yesavage JA. Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial. Trials. 2017 Sep;18(1):409.

Yesavage JA, Fairchild JK, Mi Z, Biswas K, Davis-Karim A, Phibbs CS, Forman SD, Thase M, Williams LM, Etkin A, O'Hara R, Georgette G, Beale T, Huang GD, Noda A, George MS; VA Cooperative Studies Program Study Team. Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans A Randomized Clinical Trial. JAMA Psychiatry. Published online June 27, 2018.

More Information

Study ClinicalTrials.gov site
ClinicalTrials.gov Identifier: NCT01191333